DETAILS, FICTION AND CANNABIS INDUSTRY REACTS TO RESCHEDULING PROPOSAL

We will continue on to monitor regulatory as well as other developments that will end result from your proposed rescheduling and stay up for pinpointing the best route ahead for the company and our shareholders to completely capitalize around the U.S. marijuana option.”  HHS also relied on FDA’s comprehensive evaluation of knowledge submitted